Cannabis-induced psychosis-like experiences are associated with high schizotypy

Psychopathology

Volumn 39, Issue 4, 2006, Pages 175-178

  Barkus, E J ^a   Stirling, J ^b   Hopkins, R S ^a   Lewis, S ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Cannabis; Psychosis like experiences; Schizotypy

Indexed keywords

CANNABIS;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPERIENCE; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPOTHESIS; MALE; MEASUREMENT; NORMAL HUMAN; PERSONALITY; PSYCHOLOGY; PSYCHOSIS; QUESTIONNAIRE; RATING SCALE; RISK FACTOR; SCHIZOPHRENIA; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; FEMALE; HUMANS; MALE; MARIJUANA SMOKING; PERSONALITY ASSESSMENT; PSYCHOSES, SUBSTANCE-INDUCED; QUESTIONNAIRES; RISK FACTORS; SCHIZOTYPAL PERSONALITY DISORDER;

EID: 33745218113     PISSN: 02544962     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092678     Document Type: Article

References (27)

1. Linszen DH, Dingemans PM, Lenoir ME: Cannabis abuse and the course of recent onset schizophrenia disorders. Arch of Gen Psychiatr 1994;51:273-279.
2. Baigent M, Holme G, Hafner RJ: Self reports of the interaction between substance abuse and schizophrenia. Aust NZ J Psychiatr 1995;29:69-74.
3. Van Os J, Bak M, Haussen M, Bijl RV, de Graaf R, Verdoux H: Cannabis use and psychosis: a longitudinal population based study. Am J Epidemiol 2002;156:319-327.
4. McGuire PK, Jones P, Harvey I, Williams M, McGuffin P, Murray RM: Morbid risk of schizophrenia for relatives of patients with cannabis associated psychosis. Schizophr Res 1995;15:277-281.
5. Degenhardt L, Hall W: The association between psychosis and problematic drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being. Psych Med 2001;31:659-668.
6. Arsenault L, Cannon M, Poulton R, Murray R, Caspi A, Moffit TE: Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002;325:1212-1213.
7. Williams JH, Wellman JN, Rawlins JNP: Cannabis use correlates with schizotypy in healthy people. Addiction 1996;91:869-877.
8. Kwapil TR: A longitudinal study of drug and alcohol use by psychosis-prone and impulsive-nonconforming individuals. J Abnorm Psychol 1996;105:114-123.
9. Moss R, Bardang C, Kindl K, Dahme B: Relationship between cannabis use, schizotypal traits and cognitive function in healthy subjects. Psychopathology 2001;34:209-214.
10. Dumas P, Saoud M, Bouafia S, Gutknecht C, Ecohard R, Dalēry J, Rochet T, D'Amato T: Cannabis use correlates with schizotypal personality traits in healthy students. Psychiatry Res 2002;109:27-35.
11. Skosnik PD, Spatz-Glenn L, Park S: Cannabis use is associated with schizotypy and attentional disinhibition. Schizophr Res 2001;48:83-92.
12. Thomas H: A community survey of adverse effects of cannabis use. Drug Alcohol Depend 1996;42:201-207.
13. Verdoux H, Sorbara F, Gindre C, Swendsen JD, van Os J: Cannabis use and dimensions of psychosis in a non-clinical population of female subjects. Schizophr Res 2002;59:77-84.
14. Fergusson DM, Horwood LJ, Swain-Campbell NR: Cannabis dependence and psychotic symptoms in young people. Psychol Med 2003;33:15-21.
15. Verdoux H, Gindre C, Sorbara F, Tournier M, Swendsen JD: Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychol Med 2003;33:23-32.
16. Raine A, Benishay D: The SPQ-B: a brief screening instrument for schizotypal personality disorder. Schizophr Bull 1995;23:75-82.
17. Raine A: The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull 1991;17:555-564.
18. Abood ME, Martin BR: Neurobiology of marijuana abuse. Trends Pharmacol Sci 1991;13:201-206.
19. Ames R: A clinical and metabolic study of acute intoxication with Cannabis sativa and its role in the model of psychoses. J Ment Sci 1958;104:972-999.
20. Keeler M, Ewing J, Rouse B: Hallucinogenic effects of marijuana as currently used. Am J Psychiatry 1971;128:213-216.
21. Hammer T, Vaglum P: Initiation, continuation or discontinuation of cannabis use in the general population. Br J Addict 1990;85:899-909.
22. Gaoni Y, Mechoulon R: Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc 1964;86:1646-1647.
23. Herkenham M, Lynn AB, Little MD, Ross Johnson M, Melvin LS, De Costa BR, Rice KC: Cannabinoid receptor localization in the brain. Proc Natl Acad Sci USA 1990;87:1932-1936.
24. Tanda G, Pontieri FE, Di Chiara G: Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 1997;276:2048-2050.
25. Voruganti LNP, Slomka P, Zabel P, Mattar A, Awad AG: Cannabis induced dopamine release: an in-vivo SPECT study. Psychiatry Res 2001;107:173-177.
26. Laruelle M: The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res Rev 2000;31:371-384.
27. Van Os J, Hanssen M, Bijl RV, Ravelli A: Strauss (1969) revisited: a psychosis continuum in the general population? Schizophr Res 2000;45:11-20.